2023
DOI: 10.3390/jcm12186081
|View full text |Cite
|
Sign up to set email alerts
|

Limb Salvage and Survival in Chronic Limb-Threatening Ischemia: The Need for a Fast-Track Team-Based Approach

Giorgio Ventoruzzo,
Giulia Mazzitelli,
Umberto Ruzzi
et al.

Abstract: Chronic limb-threatening ischemia (CLTI) represents the end-stage form of peripheral arterial disease (PAD) and is associated with a very poor prognosis and high risk of limb loss and mortality. It can be considered very similar to a terminal cancer disease, reflecting a large impact on quality of life and healthcare costs. The aim of this study is to offer an overview of the relationship between CLTI, limb salvage, and mortality, with a focus on the need of a fast-track team-based management that is a driver … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 55 publications
0
4
0
Order By: Relevance
“…Molecular therapies such as mesenchymal stem cells or gene therapy are currently being investigated in this field and will hopefully improve outcomes [36][37][38][39], but until the widespread use of those innovative techniques in clinical practice, it remains advisable to use team-based care to provide the best treatment option in each patient to deal with any anatomic difficulties such as ectasic veins. Close collaboration among surgeons, clinicians and biomedical engineers is crucial to tailor the treatment for each patient [40,41], similarly to the lessons of the Heart Team in cardiology. In this scenario, patient-reported outcomes play a pivotal role in evaluating the cost-effectiveness of each treatment [2,5,42] as well as circulating biomarkers to promptly detect complications even before clinical events [43].…”
Section: Discussionmentioning
confidence: 99%
“…Molecular therapies such as mesenchymal stem cells or gene therapy are currently being investigated in this field and will hopefully improve outcomes [36][37][38][39], but until the widespread use of those innovative techniques in clinical practice, it remains advisable to use team-based care to provide the best treatment option in each patient to deal with any anatomic difficulties such as ectasic veins. Close collaboration among surgeons, clinicians and biomedical engineers is crucial to tailor the treatment for each patient [40,41], similarly to the lessons of the Heart Team in cardiology. In this scenario, patient-reported outcomes play a pivotal role in evaluating the cost-effectiveness of each treatment [2,5,42] as well as circulating biomarkers to promptly detect complications even before clinical events [43].…”
Section: Discussionmentioning
confidence: 99%
“…The end-stage form of the disease, described as chronic or critical limb ischemia (CLI), affects up to 10% of patients with PAD and is characterized by a high risk of major amputation and mortality. CLI is primarily driven by progressive atherosclerotic disease [43].…”
Section: Discussionmentioning
confidence: 99%
“…Such a program requires a coordinated effort of physicians, nurses, allied health professionals, and administrators who are dedicated to the cause of treating PAD and saving and maintaining functional limbs. Prompt and appropriate diagnosis followed by a multidisciplinary approach to treatment is critical to successfully treating patients with PAD ( 4 ). Programs should incorporate risk reduction with appropriate medical therapy.…”
Section: Multidisciplinary Approach To Optimize Pad Managementmentioning
confidence: 99%